Page last updated: 2024-11-03

proglumetacin and Spondylitis

proglumetacin has been researched along with Spondylitis in 1 studies

proglumetacin : A carboxylic ester obtained by formal condensation of the carboxy group of indometacin with the hydroxy group of 3-[4-(2-hydroxyethyl)piperazin-1-yl]propyl N(2)-benzoyl-N,N-dipropyl-alpha-glutaminate. Used (as its dimaleate salt) to control pain and inflammation associated with musculoskeletal and joint disorders. Following oral administration, it is metabolised to indometacin and proglumide, a drug with antisecretory effects that helps prevent injury to the stomach lining.

Spondylitis: Inflammation of the SPINE. This includes both arthritic and non-arthritic conditions.

Research Excerpts

ExcerptRelevanceReference
"Fifty-five patients with osteoarthritis, rheumatoid arthritis or spondyloarthritis, joint pain and other rheumatic-inflammatory disorders were treated with proglumetacin, at different doses, during 3-60 days."3.66[Proglumetacin: a flexible and broad-spectrum antirheumatic agent]. ( Fontanesi, G; Giancecchi, F; Rotini, R; Tartaglia, I, 1983)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fontanesi, G1
Giancecchi, F1
Rotini, R1
Tartaglia, I1

Other Studies

1 other study available for proglumetacin and Spondylitis

ArticleYear
[Proglumetacin: a flexible and broad-spectrum antirheumatic agent].
    Minerva medica, 1983, Jun-23, Volume: 74, Issue:26

    Topics: Adolescent; Adult; Aged; Arthritis, Rheumatoid; Child; Drug Evaluation; Drug Tolerance; Female; Huma

1983